Due to the success of combined antiretroviral therapy (cART) in recent years, the
pathological outcome of Human Immunodeficiency Virus type 1 (HIV-1) infection has …

Introduction Social disruption associated with coronavirus disease 2019 (COVID‐19)
threatens to impede access to regular healthcare, including for people living with HIV …

Abstract Purpose of Review Analytical treatment interruption (ATI) remains an essential
component in clinical studies investigating novel agents or combination treatment strategies …

Background Analytical treatment interruption (ATI) is the gold standard in HIV research for
assessing the capability of new therapeutic strategies to control viremia without antiretroviral …

Background People who initiate antiretroviral therapy (ART) during acute HIV infection are
potential candidates for HIV cure-related clinical trials, as early ART reduces the size of the …

Introduction Upon the introduction of the combination antiretroviral therapy (cART), HIV
infection has become a chronic disease. However, cART is unable to eradicate the virus and …

Analytic treatment interruption (ATI) is scientifically necessary in HIV‐remission (“cure”)
studies to test the effects of new interventions. However, stopping antiretroviral treatment …

HIV-1 is able to persist in the face of potent antiretroviral therapy (ART). A number of
strategies are being explored to allow ART-free viral remission or viral eradication. In order …

Background. Analytical treatment interruption (ATI) is the gold standard in HIV research to
validate the ability of novel therapeutic strategies to long-term control viremia without …

Background: In spite of many reports on persistent low CD4 T cell counts and change in
immune-related gene expression level in patients with HIV infection, there is still uncertainty …